Venetoclax gets NICE approval for chronic lymphocytic leukaemia

18th January 2019 Uncategorised 0

The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Venclyxto to benefit thousands of adults with chronic lymphocytic leukaemia.

More: Venetoclax gets NICE approval for chronic lymphocytic leukaemia
Source: News